Louis Navellier, whose "Squawk Box" model portfolio is up 19% this year, shares his views on how to ride out the volatility in the market.» Read More
U.S. stocks closed lower as investors remained anxious over stalled Greece debt talks and the upcoming two-day Federal Reserve meeting.
CVS is buying Target's pharmacy business, but the deal shouldn't raise antitrust concerns or prices, NBC News reports.
June 15- Drugstore operator CVS Health Corp said it will acquire Target Corp's U.S. pharmacy and clinics businesses in a $1.9 billion deal that will help it bargain with drug makers for lower prices. "The addition of the Target pharmacy adds significant purchasing clout for pharmaceuticals," FBR Capital markets analyst Steven Halper wrote in a note.
Some of the names on the move ahead of the open.
June 15- Drugstore operator CVS Health Corp said it will acquire Target Corp's U.S. pharmacy and clinics businesses for about $1.9 billion to boost sales and prescription volumes. CVS's shares were up 0.4 percent at $102.65 in premarket trading on Monday, while Target's were flat at $79.50. Barclays is CVS's financial adviser, while Target's is Goldman Sachs.
CVS Health and Target on Monday announced a deal for CVS to acquire Target's pharmacy and clinic businesses for about $1.9 billion.
June 15- Drugstore operator CVS Health Corp said it will acquire Target Corp's pharmacy and clinic businesses for about $1.9 billion.
The middle class is back, and some analysts say it's time to dip into the retail stocks that could benefit the most.
Here are some of the Top Best Most wonderful discounts for seniors.
Regeneron's shares sank 4 percent despite a positive Food and Drug Administration recommendation on a cholesterol drug. What gives?
It's been quiet in the U.S. stock market this year ... too quiet.
*Deal gives Cardinal Health more generic volume. June 5- Cardinal Health Inc said it would buy privately held drug distributor Harvard Drug Group for $1.12 billion to boost volumes of its generic distribution business. The Livonia, Michigan- based Harvard Drug Group, a distributor of generic and over-the-counter drugs, had revenue of about $450 million in 2014,...
You’ve probably used the products it is inside, but “Mad Money” host Jim Cramer thinks you need to get your hands on the stock.
Jim Cramer kicks off his healthcare hot list with one scorching name that does well in a slow growth economy.
The "Halftime Report" traders give their top trades before the closing bell.
Is your portfolio exposed to issues overseas? “Mad Money” host Jim Cramer has answers.
"Fast Money" traders discussed how to play retailer Gap's mixed earnings report and CVS' acquisition of Omnicare.
Jim Cramer considers this group to be the single best out there, and it's ready to pull off some big deals.
Jim Cramer warns investors about falling into a trap based on snap decisions that could burn cash.
*Shake Shack hits record on trademark filing. May 21- U.S. stocks rose in afternoon trading on Thursday, with the S&P 500 just shy of its record high and the Nasdaq crossing its record close, as disappointing economic data bolstered the view that an interest rate hike would come only later in the year. Federal Reserve officials all but ruled out a rate hike next month...